Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Cannabis Inc. is a pioneering company in the hemp and cannabinoid industry, recognized as the first publicly traded cannabis company in the United States. The company operates through a portfolio of subsidiaries and investments focused on the development, marketing, and sale of hemp-based CBD products. Its business model encompasses the entire supply chain, from seed to consumer, providing botanical products for the nutraceutical, pharmaceutical, and cosmeceutical markets. Key brands under its umbrella include HempMeds and Kannaway, which distribute CBD-rich hemp oil products globally. The company's mission is to provide access to high-quality cannabinoid products while advancing the scientific understanding of hemp's therapeutic potential.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Cannabis.